Cytokine Storm Syndrome

Cytokine Storm Syndromes, including HLH and MAS, are frequently fatal disorders, particularly if not recognized early and treated during presentation. The genetics of Cytokine Storm Syndromes are being defined with many of the risk alleles giving rise to mutations in the perforin-mediated cytolytic...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Cron, Randy Q. (Editor), Behrens, Edward M. (Editor)
Format: Electronic eBook
Language:English
Published: Cham : Springer International Publishing : Imprint: Springer, 2024.
Edition:2nd ed. 2024.
Series:Advances in Experimental Medicine and Biology, 1448
Subjects:
Online Access:https://doi.org/10.1007/978-3-031-59815-9
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000nam a22000005i 4500
001 978-3-031-59815-9
003 DE-He213
005 20251113173832.0
007 cr nn 008mamaa
008 240809s2024 sz | s |||| 0|eng d
020 |a 9783031598159  |9 978-3-031-59815-9 
024 7 |a 10.1007/978-3-031-59815-9  |2 doi 
050 4 |a QR180-189.5 
072 7 |a MJCM  |2 bicssc 
072 7 |a MED044000  |2 bisacsh 
072 7 |a MJCM  |2 thema 
082 0 4 |a 571.96  |2 23 
082 0 4 |a 616.079  |2 23 
245 1 0 |a Cytokine Storm Syndrome  |h [electronic resource] /  |c edited by Randy Q. Cron, Edward M. Behrens. 
250 |a 2nd ed. 2024. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2024. 
300 |a XVI, 628 p. 43 illus., 35 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
341 0 |b Table of contents navigation  |2 onix 
341 0 |b Single logical reading order  |2 onix 
341 0 |b Short alternative textual descriptions  |2 onix 
341 0 |b Use of color is not sole means of conveying information  |2 onix 
341 0 |b Use of high contrast between text and background color  |2 onix 
341 0 |b Next / Previous structural navigation  |2 onix 
341 0 |b All non-decorative content supports reading without sight  |2 onix 
347 |a text file  |b PDF  |2 rda 
490 1 |a Advances in Experimental Medicine and Biology,  |x 2214-8019 ;  |v 1448 
505 0 |a 1. Cytokines in cytokine storm syndromes -- 2. History of HLH -- 3. The history of macrophage activation syndrome in autoimmune diseases -- 4. Clinical features of cytokine storm syndromes -- 5. Laboratory features and pathology of cytokine storm syndromes -- 6. Criteria for cytokine storm syndromes -- 7. Familial HLH genetics -- 8. Secondary HLH genetics -- 9. Genetics of macrophage activation syndrome in systemic juvenile idiopathic arthritis -- 10. CD8+ T cell biology in cytokine storm syndromes -- 11. Immunology of cytokine storm syndromes: Natural killer cells -- 12. Myeloid cells in the immunopathogenesis of cytokine storm syndrome -- 13. Cytokine storm -- 14. Primary immunodeficiencies -- 15. Infectious triggers of cytokine storm syndromes: Herpes virus family (non-EBV) -- 16. CSS associated with Epstein Barr Virus -- 17. Hemorrhagic Fever and other viruses -- 18. Cytokine storm syndrome as a manifestation of primary HIV infection -- 19. Bacteria-associated cytokine storm syndrome -- 20. Zoonoticbacterial infections triggering cytokine storm syndrome -- 21. Parasitic and fungal triggers -- 22. COVID-19 pneumonia and cytokine storm syndrome -- 23. Cytokine storm associated with Systemic Juvenile Idiopathic Arthritis -- 24. Systemic lupus erythematosus -- 25. Kawasaki disease -- 26. The intersections of autoinflammation and cytokine storm -- 27. Other rheumatic triggers -- 28. Multisystem Inflammatory Syndrome in children -- 29. Hemophagocytic lymphohistiocytosis in the context of hematological malignancies and solid tumors -- 30. Cytokine storm and sepsis-induced Multiple Organ Dysfunction Syndrome -- 31. The cytokine storm of Multicentric Castleman Disease -- 32. Cytokine storm syndromes associated with pregnancy and therapeutics -- 33. fHLH models -- 34. sHLH models -- 35. Etoposide therapy of CSS -- 36. IL-1 family blockade -- 37. IL-6 blockade -- 38. IFNy blockade -- 39. JAK inhibitors -- 40. Other immunomodulatory HLH treatments -- 41. Salvage therapy for HLH. 
520 |a Cytokine Storm Syndromes, including HLH and MAS, are frequently fatal disorders, particularly if not recognized early and treated during presentation. The genetics of Cytokine Storm Syndromes are being defined with many of the risk alleles giving rise to mutations in the perforin-mediated cytolytic pathway used by CD8 cytotoxic T cells and natural killer cells. These are being studied using murine models. Up to 10% of the general population may carry risk alleles for developing Cytokine Storm Syndromes, and Cytokine Storm Syndromes are being increasingly recognized around the world in pediatric and adult hospitals. A variety of infectious, rheumatic, and oncologic triggers are commonly associated with Cytokine Storm Syndromes, but understanding this disorder is critical for all researchers and physicians to ensure timely and appropriate therapy. This second edition addresses all aspects of the disorder, from genetics, pathophysiology, and ongoing research, to clinical presentations, risk factors and treatment. New-to-this-edition features include dedicated chapters on severe COVID-19 CSS, and post-COVID CSS of multi-system inflammatory syndrome in children (MIS-C). In addition, novel topics including CSS associated with Castleman disease, pregnancy, therapeutics, transplantation, and cardiac bypass, as well as treatment with JAK inhibitors are addressed. . 
532 8 |a Accessibility summary: This PDF does not fully comply with PDF/UA standards, but does feature limited screen reader support, described non-text content (images, graphs), bookmarks for easy navigation and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com. 
532 8 |a No reading system accessibility options actively disabled 
532 8 |a Publisher contact for further accessibility information: accessibilitysupport@springernature.com 
650 0 |a Immunology. 
650 0 |a Molecular genetics. 
650 0 |a Diseases. 
650 0 |a Cytokines. 
650 1 4 |a Immunology. 
650 2 4 |a Molecular Genetics. 
650 2 4 |a Diseases. 
650 2 4 |a Cytokines and Growth Factors. 
700 1 |a Cron, Randy Q.  |e editor.  |0 (orcid)0000-0003-2661-3086  |1 https://orcid.org/0000-0003-2661-3086  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Behrens, Edward M.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783031598142 
776 0 8 |i Printed edition:  |z 9783031598166 
776 0 8 |i Printed edition:  |z 9783031598173 
830 0 |a Advances in Experimental Medicine and Biology,  |x 2214-8019 ;  |v 1448 
856 4 0 |u https://doi.org/10.1007/978-3-031-59815-9 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708)